Effects of continuous treatment with superagonists of LHRH when initiated at different times of the menstrual cycle in female baboons.
D000818:Animals; D004343:Drug Implants; D004958:Estradiol / Q000378:metabolism; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007986:Luteinizing Hormone / Q000378:metabolism; D008598:Menstruation / Q000187:drug effects*; D010215:Papio; D010502:Perineum / Q000187:drug effects; D011374:Progesterone / Q000097:blood; D012867:Skin / Q000187:drug effects; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000031:analogs & derivatives*
D004343:Drug Implants; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol; C010661:surfagon; C019176:Tryptal; D007986:Luteinizing Hormone